
Inspired by the human element
to advance cell therapy
Determined to deliver what's


Dedicated to quality and driven by excellence, we are committed to improving the lives of patients worldwide. We are steadfast in our goal to develop innovative cellular therapies that bring us closer to a cure.
From the very beginning, we’ve been focused on science. We came together as a team of experts dedicated to quality, driven by excellence, and committed to experimentation. Though we faced many challenges, we remain fearless in our research and rigorous in our thinking, pushing ourselves to work harder.
At Legend Biotech, we have the opportunity to change the way treatments are developed across diseases and continents. Our goal is to reinvigorate treatment approaches in oncology and beyond.
The spark of hope is lit and we’re using that hope to ignite the future of cell therapy!
We welcome the opportunity to reinvigorate the treatment approaches in oncology and the future of cell therapy.
Today, our research is focused on continuous innovation in the field of cell therapy. We are also future-focused on emerging technologies that can help address some of the most chronic and life-threatening diseases.
Our goal is to reimagine healthcare and to deliver transformative treatments.
And at Legend Biotech, that’s what we’re doing every day.
Our driving force at Legend Biotech is sharing our passion for developing cutting-edge cell therapies with our colleagues and the healthcare community. We do that through:
Patient First: We keep patients at the forefront of our work.
Integrity: We value honesty, ethical business conduct and transparency.
Innovation: We promote a creative culture to drive scientific breakthroughs and continuous improvement.
Accountability: We deliver on our commitments.
Passion: We approach our work with dedication and enthusiasm.
Collaboration: We embrace differences, communicate openly and build trust.
At Legend, we are striving to make a difference in health care, to improve the lives of patients, and to build sustainable value for our stockholders. Achieving these goals depends largely on our commitment to conducting business ethically. For more information, please review our Code of Conduct.
Our Code: is a summary of ethical and compliance principles that guide the company’s operations and employees. For more information, please review our Code of Conduct.
Legend Biotech maintains a comprehensive compliance program to foster compliance with the laws, industry guidelines and company standards. Legend Biotech’s Comprehensive Compliance Program has been developed in accordance with the California Health and Safety Code § 119400 and 119402, and represents a good faith understanding of the regulation.
Read about our Comprehensive Compliance Program.
For questions about our Compliance Program, please contact compliance@legendbiotech.com.
Chief Executive Officer
Chief Financial Officer
Senior Vice President, Global Business Development
Senior Vice President, Global Head of Research and Early Development
Senior Vice President, Global Technical Operations
Vice President, Commercial Development, US & Europe
Vice President, Early-stage Drug Development
Vice President, General Counsel
Vice President, Global Quality
Vice President, Clinical Development, Greater China
Vice President, Clinical Development
Vice President, Global Regulatory Affairs
Vice President, Research & Development, Greater China
Vice President of Commercial Development, Greater China
Board Chairwoman, Legend Biotech
President, GenScript Inc.
Board Member, Legend Biotech
Board Member, Legend Biotech
Board Member, Molecular Templates
Board Member, AbGenomics
Board Member, Legend Biotech,
Chairman and CEO, Elpiscience Biopharmaceuticals
Board Member, Legend Biotech
Board Member, Legend Biotech
Board Member, Legend Biotech
Legend Biotech has entered into a worldwide collaboration and license agreement with Janssen Biotech, Inc., one of the Janssen Pharmaceutical Companies of Johnson & Johnson, to develop, manufacture, and commercialize ciltacabtagene autoleucel (cilta-cel)a,b. Under the terms of the agreement, Legend and Janssen are co-developing and will co-commercialize cilta-cel in select countries. Manufacturing of ciltacabtagene autoleucel for commercial distribution worldwide will be done in partnership with Janssen.
The safety and efficacy of the agents and/or uses under investigation have not been established. There is no guarantee that the agents will receive health authority approval or become commercially available in any country for the uses being investigated.
Ciltacabtagene autoleucel (cilta-cel) is an investigational B cell maturation antigen (BCMA) targeted chimeric antigen receptor T cell (CAR-T) therapy. It is being evaluated for the treatment of patients with multiple myeloma by regulatory authorities around the world.
Legend Biotech has established a research collaboration with Beth Israel Deaconess Medical Center (BIDMC), an academic medical center affiliated with Harvard Medical School, to investigate a chimeric antigen receptor T (CAR-T) cell therapy approach for Human Immunodeficiency Virus (HIV) infections.
Dan H. Barouch, MD, PhD, Director of the Center for Virology and Vaccine Research at BIDMC, a leading researcher in virology with extensive experience in preclinical and clinical studies, serves as the principal investigator for the collaboration.
Under the terms of the agreement, Legend Biotech will engineer and provide CAR-T cell candidates against specific targets that may affect HIV viral load suppression and disease control. Dr. Barouch and team will focus on preclinical studies, and a clinical proof-of-concept study as appropriate.
At Legend Biotech, we are transforming the world of oncology and medicine, and always looking for people who can help contribute to the strength of our team and to our shared values.
We are actively hiring across multiple functions and levels to strengthen our world-class team with our goal and commitment to improving patients’ lives through transformative science and medicine.
To view and apply for one of our current open positions, visit our
LinkedIn Careers page.You are about to leave LegendBiotech.com.
Are you sure you want to leave so soon?